# Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

> **NCT06023186** · — · RECRUITING · sponsor: **Michael Ayers** · enrollment: 20 (estimated)

## Conditions studied

- Obstructive Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** mavacamten

## Key facts

- **NCT ID:** NCT06023186
- **Lead sponsor:** Michael Ayers
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-03
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06023186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06023186, "Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06023186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*